Baxter International (BAX) Long-Term Debt Repayments (2009 - 2025)
Baxter International (BAX) reported Long-Term Debt Repayments of $600.0 million for Q4 2025, down 67.21% year-over-year from $1.8 billion in Q4 2024, and down 11.76% quarter-over-quarter from $680.0 million in Q2 2025.
Baxter International (BAX) Long-Term Debt Repayments (2009 - 2025) Analysis & Trends
Baxter International (BAX) has 15 years of Long-Term Debt Repayments data on file, last reported at $600.0 million in Q4 2025.
- Long-Term Debt Repayments for Q4 2025 came in at $600.0 million, down 67.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 76.59% YoY), and the FY2025 annual result was $5.5 billion, up 106.59% from the prior year.
- Long-Term Debt Repayments retreated to $600.0 million in Q4 2025 per BAX's latest filing, from $680.0 million in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $2.8 billion in Q1 2025 and troughed at $1.0 million in Q4 2022.
- A 5-year average of $810.6 million and a median of $405.5 million in 2021 frame the typical range for Long-Term Debt Repayments.
- The sharpest annual moves came in 2022 and 2023: Long-Term Debt Repayments slumped 99.96% in 2022, then soared 228000.0% in 2023.
- A 5-year view of Long-Term Debt Repayments shows it stood at $2.4 billion in 2021, then tumbled by 99.96% to $1.0 million in 2022, then soared by 228000.0% to $2.3 billion in 2023, then retreated by 19.77% to $1.8 billion in 2024, then plunged by 67.21% to $600.0 million in 2025.
- Business Quant data shows BAX's Long-Term Debt Repayments at $600.0 million in Q4 2025, $680.0 million in Q2 2025, and $2.8 billion in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.00 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 876.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 127.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600.00 Mn |
| Dec 31, 2025 | 600.00 Mn |
| Jun 30, 2025 | 680.00 Mn |
| Jun 30, 2025 | 680.00 Mn |
| Mar 31, 2025 | 2.83 Bn |
| Mar 31, 2025 | 2.83 Bn |
| Dec 31, 2024 | 1.83 Bn |
| Dec 31, 2024 | 1.83 Bn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 809.00 Mn |
| Jun 30, 2024 | 809.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 2.28 Bn |
| Dec 31, 2023 | 2.28 Bn |
| Sep 30, 2023 | 211.00 Mn |
| Sep 30, 2023 | 211.00 Mn |
| Jun 30, 2023 | 139.00 Mn |
| Jun 30, 2023 | 139.00 Mn |